NR 566 Week 5 Assignment; Immunization - Recommendations for Human Papillomavirus and Hepatitis B
-
$15.00
| Institution | NR 566 Advanced Pharmacology for Care of the Family |
| Contributor | Shanzay |
Diptheria, tetanus & acellular pertussis (DTaP) | Haemophilus influenza type b (Hib) |
Hepatitis B | Human papillomavirus (HPV) |
Inactivated influenza (IIV) | Inactivated poliovirus (IPV) |
Influenza recombinant (RIV) | Live influenza (LAIV) |
Measles, mumps & rubella (MMR) | Meningococcal serogroups A, C, W, Y) |
Meningococcal serogroup B | Pneumococcal 13-valent conjugate (PCV13) |
Pneumococcal 23-valent polysaccharide (PPSV23) | Rotavirus |
Tetanus, diphtheria & acellular pertussis (Tdap or Td) | Varicella (VAR) |
Zoster live | Zoster recombinant |
Choose 2 vaccines from the list above and provide the following information for each:
- Name of disease preventable vaccination
- Trade name (if more than one available, chose one only)
- Type of vaccination (attenuated or inactivated)
- Contraindications
- Precautions
- Adverse drug reactions
- Minimum age to receive vaccine
- Routine recommended vaccine schedule (timing and dose)
- Special situations
Example:
Vaccination: Hepatitis A vaccination
Trade Name: Havrix
Type: Inactivated
Contraindication: Person with previous history of severe reaction to HAV, moderate or severe illness, with or without fever
Precautions: Patients with immunosuppression (may have lower antibody titers)
Adverse drug reactions: Injection site reaction, headache & malaise
Minimum age: 12 months
Routine vaccination schedule: 2 dose series between ages 12-24 months
Minimum interval between doses (if applicable): 6 months apart
Special situations: Vaccine should be given to those at risk for hepatitis A infection including chronic liver disease, clotting factor disorders, men who have sex with men, injection or non-injection drug use, homelessness, work with hepatitis a virus, travel in countries with high or intermediate endemic hepatitis A or close personal contact with an international adoptee.
Barriers & Interventions
- Identify one reason for vaccine non-compliance or vaccine hesitancy by patients/parents.
- Discuss one intervention that Nurse Practitioners can take to improve vaccination compliance .
- Identify when healthcare providers are required by law to report an adverse event.
- Discuss adverse events that healthcare providers are encouraged to report.
- Identify how a healthcare provider would report an adverse event.
| Instituition / Term | |
| Term | Spring 2021 |
| Institution | NR 566 Advanced Pharmacology for Care of the Family |
| Contributor | Shanzay |
